Search

1. Oncology pharmaceuticals: reproductive toxicity testing and labeling recommendations

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2019

Subject(s):

Antineoplastic Agents -- adverse effects
Mutagenicity Tests -- standards
Neoplasms -- drug therapy
Reproduction -- drug effects
Teratogens
Toxicity Tests -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2. Novel agents to prevent chemotherapy-induced neutropenia and other myelosuppressive effects: revised evidence report

Author(s):

Tice, Jeffrey A., author
McKenna, Avery, author
Herce-Hagiwara, Belén, author
Moradi, Ashton, author
Pearson, Steven D., author
Ollendorf, Daniel A., author
Bloudek, Lisa, author
Carlson, Josh J., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 17, 2022

Subject(s):

Antineoplastic Agents -- adverse effects
Chemotherapy-Induced Febrile Neutropenia -- drug therapy
Chemotherapy-Induced Febrile Neutropenia -- prevention & control
Neutropenia -- drug therapy
Neutropenia -- prevention & control
United States